Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens
Clinical trial NCT00419081 · TERMINATED
Trial details
- NCT number
- NCT00419081
- Sponsor
- BioCryst Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2007-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.